TerminatedPhase 4NCT00333385
Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis
Studying Cystic fibrosis-gastritis-megaloblastic anemia syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
- Principal Investigator
- Dominique Hubert, MDAssistance Publique - Hôpitaux de Paris
- Intervention
- ceftazidime(drug)
- Enrollment
- 120 target
- Eligibility
- 8 years · All sexes
- Timeline
- 2001 – 2004
Study locations (15)
- CHU Grenoble, Grenoble, France
- Centre hospitalier Dr Schaffner, Lens, France
- Hopital Albert Calmette, Lille, France
- Hopital Jeanne de Flandre, Lille, France
- Hopital Sainte Marguerite, Marseille, France
- Assistance Publique des hopitaux de paris, Hopital Trousseau, Paris, France
- Assistance Publique des Hopitaux de Paris, Hopital Cochin, Paris, France
- Assistance Publique des Hopitaux de Paris, Hopital Necker, Paris, France
- Assistance Publique des Hopitaux de Paris, Hopital Robert Debré, Paris, France
- Hopital Sud, Rennes, France
- Centre Héliomarin, Roscoff, France
- Hopital Hautepierre, Strasbourg, France
- Hopital Foch, Suresnes, France
- Hopital Larrey, Toulouse, France
- Hopital de Brabois, Vandœuvre-lès-Nancy, France
Collaborators
Vaincre la Mucoviscidose · GlaxoSmithKline · Baxter Healthcare Corporation · Roche Pharma AG
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00333385 on ClinicalTrials.govOther trials for Cystic fibrosis-gastritis-megaloblastic anemia syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07071324CF Wellness ProgramJohns Hopkins University
- RECRUITINGNANCT07223255Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean DietDartmouth-Hitchcock Medical Center
- RECRUITINGNANCT07031323OnTrackCF: Engagement, Feasibility, and Acceptability StudyBoston Children's Hospital
- ACTIVE NOT RECRUITINGNCT07147803Sleep Quality in Patients With Non-cystic Fibrosis BronchiectasisAssiut University
- RECRUITINGPHASE2NCT06998043Study With Phage for CF Subjects With Pseudomonas Lung InfectionBiomX Ltd
- RECRUITINGNCT06683092Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)Boston Children's Hospital
- RECRUITINGPHASE2NCT06559150A Phase II Study of Ensifentrine in Non-Cystic Fibrosis BronchiectasisVerona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
- RECRUITINGPHASE4NCT05704036Estrogen Supplementation and Bone Health in Women With CFJohns Hopkins University
See all trials for Cystic fibrosis-gastritis-megaloblastic anemia syndrome →